Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization
Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization
复制标题
DOI:
10.1074/jbc.m605273200
复制
发表时间:
2006-09-01
影响因子:
4.8
通讯作者:
Henske, Elizabeth Petri
中科院分区:
文献类型:
--
作者:
Karbowniczek, Magdalena;Robertson, Gavin P.;Henske, Elizabeth Petri
The Ras-Raf-MEK signaling cascade is critical for normal development and is activated in many forms of cancer. We have recently shown that B-Raf kinase interacts with and is inhibited by Rheb, the target of the GTPase-activating domain of the tuberous sclerosis complex 2 gene product tuberin. Here, we demonstrate for the first time that activation of Rheb is associated with decreased B-Raf and C-Raf phosphorylation at residues Ser-446 and Ser-338, respectively, concomitant with a decrease in the activities of both kinases and decreased heterodimerization of B-Raf and C-Raf. Importantly, the impact of Rheb on B-Raf/C-Raf heterodimerization and kinase activity are rapamycin-insensitive, indicating that they are independent of Rheb activation of the mammalian target of rapamycin-Raptor complex. In addition, we found that Rheb inhibits the association of B-Raf with H-Ras. Taken together, these results support a central role of Rheb in the regulation of the Ras/B-Raf/C-Raf/MEK signaling network.